Medical Advisory Board
Gregory W. Albers, M.D.
Dr. Albers is the Coyote Foundation Professor of Neurology and Neurological Sciences at the Stanford University Medical Center in Palo Alto, California. He has been the Director of the Stanford Stroke Center at Stanford University Medical Center since 1992. He also is Director of the Accreditation Council for Graduate Medical Education Vascular Neurology Residency Training Program at Stanford University Medical Center. Dr. Albers earned his M.D. at the University Of California School of Medicine in San Diego. He completed his internship at the Stanford University Medical Center and his residency at Stanford University Department of Neurology and Neurological Sciences. His fellowship in cerebrovascular disease was also conducted at Stanford University Medical Center. Dr. Albers has directed over 75 clinical stroke trials and authored or coauthored more than 200 articles, book chapters, and monographs concerning stroke and related topics. His articles have been published in journals such as Annals of Neurology, Neurology, JAMA and the New England Journal of Medicine. Dr. Albers has authored numerous national and international stroke guidelines and is a Senior Editor of the ACCP Consensus Guidelines on Antithrombotic therapy. He has given frequent national and international invited presentations on cerebrovascular disorders. He is a member of the American Academy of Neurology, the American Medical Association, the Bay Area Stroke Society, the American Neurological Association, the National Stroke Association, and the American Heart Association Council on Stroke. Dr. Albers is the recipient of numerous honors and awards, including the Lysia Forno Award for Teaching Excellence presented by Stanford University Medical Center. He is listed in Best Doctors in America, Best Doctors in Silicon Valley, and Best Bay Area Doctors.
Kyra J. Becker, M.D., F.A.H.A.
Dr. Becker is a stroke and critical care neurologist and Associate Professor of Neurology at the University of Washington. She is currently Co-Director of the University of Washington Stroke Center at Harborview Medical Center. Her academic training included neurology residency and a neurologic intensive care fellowship at Johns Hopkins Hospital and a stroke research fellowship in stroke at the National Institutes of Health (NIH). Dr. Becker's basic research interests are focused on immune-mediated brain injury in acute stroke, and she currently holds several grants to study lymphocyte-mediated brain injury following stroke. Dr. Becker's work in inflammatory mechanisms in brain injury following stroke earned her the American Heart Association's Robert G. Siekert New Investigator Award in Stroke, as well as a patent for the work.
Rodney D. Bell, M.D.
Dr. Bell is Professor of Neurology at Thomas Jefferson University; and Director of the Division of Neurological Critical Care, and Co-Director of the Neurosensory Intensive Care Unit at Thomas Jefferson University Hospital. He is the program director for the fellowships in Vascular Neurology and Neuro-Critical Care. Dr. Bell founded the Jefferson Cerebrovascular Center in 1985, and co-founded the Philadelphia Stroke Council, a grass roots organization dedicated to improving stroke care in the Philadelphia area. In these roles, Dr. Bell has been active in public and physician education for the prevention of stroke. Dr. Bell's research focuses on clinical trials of pharmacological treatments for acute stroke. He has also been involved in new treatments such as brain perfusion in acute stroke patients. He is currently focusing on the critical care management of stroke.
Joseph P. Broderick, M.D.
Dr. Joseph Broderick is Professor and Chairman of the Department of Neurology at the University of Cincinnati Medical Center since 2000 and a full-time member of the Department since 1987. He graduated from the University of Cincinnati Medical School in 1982 where he ranked first in his medical school class. He received his medical neurologic training and completed a Cerebrovascular fellowship at the Mayo Clinic in Rochester, MN. Dr. Broderick is an internationally recognized expert on the acute treatment of stroke and epidemiology of stroke and has had extensive involvement with hemorrhagic stroke. He is currently the Director of the Greater Cincinnati/Northern Kentucky Stroke Team and Cerebrovascular Research Program at the University of Cincinnati. He has over 460 publications and has received numerous awards including the 2003 William M. Feinberg Award for Excellence in Clinical Stroke from the Stroke Council of the American Stroke Association. He also has been named as one of the Best Heart & Stroke Physicians in the United States by Good Housekeeping and one of Best Doctors in America (National Survey – Woodward-White).
Sandra Kopit Cohen, M.D.
Dr. Cohen is a psychiatrist and psychoanalyst in private practice in Manhattan and on the faculty of Weill-Cornell Medical School and The New York Presbyterian Hospital, where she teaches Administrative Psychiatry. Dr. Cohen's expertise includes organizational and occupational psychiatry, and psychoneuroimmunology. She is working to integrate modern technology, such as the Internet, with traditional communication methods to educate professional and public audiences. Dr. Cohen has designed professional conferences in several areas, including organizational and occupational psychiatry, psychoanalysis, and women's health, and has created community outreach programs to improve public access to psychoanalytic information and treatment.
Dr. Cramer is Professor of Neurology and Anatomy & Neurobiology at the University of California, Irvine. He is also the Vice Chair for Research, the Clinical Director of the Stem Cell Research Center, and the Director of the Neuroimaging Core of the UC Irvine Institute for Clinical & Translational Science. Dr. Cramer graduated with Highest Honors from University of California, Berkeley; received his medical degree from University of Southern California; did a residency in internal medicine at UCLA; and did a residency in neurology plus and a fellowship in cerebrovascular disease at Massachusetts General Hospital. He also earned a Masters Degree from Harvard Medical School in Clinical Investigation. His research focuses on brain repair after central nervous system injury in humans, with an emphasis on recovery of movement after stroke. He co-edited the book "Brain Repair after Stroke," is an Assistant Editor at the journal Stroke, and is the author of over 100 articles.
Pamela Woods Duncan, Ph.D., F.A.P.T.A., F.A.H.A.
Dr. Duncan, is a nationally and internationally renowned physical therapist, epidemiologist and faculty member of Duke University. She is a Professor in the Division of Physical Therapy in the Department of Community and Family Medicine and a Professor and Bette Busch Maniscalco Research Fellow. Her secondary appointment is Senior Fellow at the Duke Center for Clinical Health Policy Research. She leads funded research programs on assessment of stroke outcomes, patterns of recovery, and randomized clinical trials on rehabilitation intervention. She is currently PI of a multi-site phase III clinical trial to evaluate walking recovery programs for persons post-stroke.
Karen L. Furie, M.D., M.P.H.
Dr. Furie is Director of the Massachusetts General Hospital (MGH) Stroke Service. Dr. Furie is an Associate Professor of Neurology at Harvard Medical School and an Associate Neurologist at MGH. She serves as Director of the J. Philip Kistler MGH Stroke Research Center and the Deane Institute for Integrative Research in Stroke and Atrial Fibrillation. Dr. Furie has been actively involved in diverse aspects of stroke clinical trials, and is currently serving as the Principal Neurologist for the Insulin Resistance Intervention in Stroke trial. In addition, her research has focused on stroke biomarkers, including neuroimaging and genetic determinants of stroke. Dr. Furie is the Principal Investigator for the Partners Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) and the Center Director of the Harvard American Stroke Association-Bugher Foundation Center for Stroke Prevention Research. Dr. Furie and her colleagues have made significant contributions to stroke prevention through research and efforts to educate health care professionals and the lay community. Current translational research projects offer the potential to further reduce stroke risk and improve outcomes for stroke victims.
Larry B. Goldstein, M.D., F.A.A.N., F.A.H.A.
Dr. Goldstein is Professor of Medicine (Neurology) at Duke University and the Durham VA Medical Center; Director of the Duke Center for Cerebrovascular Disease and the Duke Stroke Center, and Senior Fellow in the Duke Center for Clinical Health Policy Research and Education. Dr. Goldstein's interests include primary and secondary stroke prevention, optimizing poststroke recovery, and improving the systems of delivery of stroke-related care. His laboratory work has focused on pharmacological effects on recovery after focal brain injury. Dr. Goldstein is PI for a multi-center study of pharmacotherapy for post-stroke recovery. He serves on leadership and oversight committees for multi-center clinical trials, and is an active leader in voluntary health organizations focused on stroke and cardiovascular disease.
Philip B. Gorelick, M.D., M.P.H, F.A.C.P.
Dr. Gorelick is the John S. Garvin Professor and Head, Department of Neurology and Rehabilitation University of Illinois College of Medicine at Chicago, and Director of the Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine. Dr. Gorelick has numerous publications in the areas of stroke prevention and risk factor identification, vascular dementia, and stroke in African Americans. He has received continuous funding from the US National Institute of Health (NIH) from1987-2005. He has led two important NIH initiatives, The African American Antiplatelet Stroke Prevention Study, a recurrent stroke prevention clinical trial, and Risk Markers for Dementia After Stroke, an advanced imaging study to determine epidemiologic and MRI markers for vascular dementia and vascular cognitive impairment. Dr. Gorelick is Editor-in-Chief Emeritus of Neuroepidemiology; a member of the Editorial Board of Stroke; a recipient of the National Stroke Association (NSA) Visionary in Practice Society Award 2000, the William Feinberg Excellence in Clinical Stroke 2004, the Golden Apple and AOA Teacher of the Year Awards; past Chair of the NSA Stroke Prevention Advisory Board and a past member of the Board of Directors of the Midwest Affiliate of the American Heart Association; and a recipient of a Good Housekeeping Citation for one of the top US stroke physicians. Also, he has been awarded the Gainey Lectureship at Mayo Clinic in 2005 and the Henry Barnett Lectureship in Canada in 2005, and is presently the Chair of the International Stroke Conference of the American Heart Association; a member of the American Stroke Association Stroke Advisory Board; and a member of the National Stroke Association Board of Directors.
James C. Grotta, M.D.
Formerly Chairman of Neurology and Director of Stroke Program, UT Medical School, Houston, Dr. James Grotta received his education at Dartmouth College and his medical training at the Universities of Virginia and Colorado, and at Massachusetts General Hospital before joining the faculty at UT-Houston in 1979. He also spent two years in the U.S. Public Health Service (Indian Health Service).
Dr. Grotta has devoted his career to translational research in discovering, testing, and applying new therapies for acute stroke. He has been funded by the National Institutes of Health (NIH) and American Stroke Association for laboratory studies on the biology of brain injury and recovery in animal stroke models. He has played a leadership role in many clinical research studies of both thrombolytic drugs and cytoprotective agents after stroke, including the NINDS TPA Stroke Study, and more recently the Specialized Program for Translational Research in Acute Stroke to carry out a series of novel pilot studies aimed at amplifying the existing benefits of intravenous TPA (Tissue Plasminogen Activator).
Dr. Grotta has orchestrated a collaborative network between the UT Stroke Team, Memorial Hermann Hospital, Houston Fire Department-Emergency Medical Services, and other regional stroke centers to increase the delivery of appropriate therapy to a large number of acute stroke patients in Houston. He has extended these efforts to rural areas through regional educational programs and, more recently, telemedicine.
In 2013, Dr Grotta stepped down as Department Chair and moved his practice to Memorial Hermann Hospital to lead the Mobile Stroke Unit Consortium, raising money and coordinating efforts to successfully deploy the nation's first Mobile Stroke Unit to deliver TPA and other stroke therapies wherever the stroke occurs within the first minutes after onset.
Dr. Grotta has been an editor of the Annals of Neurology, Stroke and many other peer reviewed journals, and has been a member of several NIH and FDA review panels.
He was a recipient of the Feinberg Award for Excellence in Clinical Stroke (1999), Physician of the Year (2006), and the Eugene Braunwald Academic Mentorship Award (2010), all from the national chapter of the American Heart Association (AHA), and Dean's and President's awards for teaching and research excellence at UT Medical School. He has authored or co-authored more than 300 articles in peer-reviewed journals.
Patricia Denise Hurn, Ph.D.
Dr. Hurn is Associate Vice Chancellor for Health Research at The University of Texas System in Austin and Research Professor in Neurobiology in the College of Natural Sciences at The University of Texas at Austin. She is a cerebrovascular physiologist with specific research interests in gender differences and the role of sex steroids in brain injury. Dr. Hurn's research team has explored extensively the role of estrogen in protecting the brain-at-risk for stroke. Her work is focused on cellular mechanisms of brain damage in stroke, with particular emphasis on the role of female reproductive steroids, estrogen and progesterone. In addition to her leadership activities, Dr. Hurn continues to hold NIH grants to study stroke, which are centered on gender differences in stroke.
S. Claiborne Johnston, M.D., Ph.D.
Dr. Johnston is the Director of the Stroke Service at the University of California, San Francisco, where he is Professor of Neurology and Epidemiology. He is also Associate Vice Chancellor of Research and Director of the UCSF Clinical & Translational Science Institute. He received his undergraduate education at Amherst College and completed medical school at Harvard University. He received a Ph.D. in epidemiology from the University of California, Berkeley. Dr. Johnston has published extensively in the prevention and treatment of stroke and transient ischemic attack. He is perhaps best known for his studies describing the short-term risk of stroke in patients with transient ischemic attack and identifying patients at greatest risk, and also for his work related to measuring the impact of research. He has led several large cohort studies of cerebrovascular disease and two multicenter randomized trials. Dr. Johnston is the Executive Vice Editor of the Annals of Neurology and has served on the editorial boards of several other journals. He has been honored previously with the American Academy of Neurology's Pessin Prize for Stroke Leadership, the American Stroke Association's Siekert New Investigator Award and the Feinberg Award for Clinical Stroke Excellence.
Chelsea S. Kidwell, M.D.
Dr. Kidwell is Professor of Neurology and Medical Imaging, Vice Chair of Research in the Department of Neurology, and a member of the Sarver Heart Center. Dr. Kidwell is also Co-Medical Director of the University of Arizona Medical Center (UAMC) certified Primary Stroke Center. Dr. Kidwell's clinical research focuses on 1) innovative neuroimaging approaches directed at understanding stroke pathophysiology and treatment, 2) reducing health disparities in stroke care, and 3) advancing novel treatments for acute stroke including intracerebral hemorrhage. Dr. Kidwell is the author of over 100 peer-reviewed journal publications and 15 book chapters.
Steven J. Kittner, M.D., M.P.H.
Dr. Kittner is Professor of Neurology and Director of the Maryland Stroke Center, University of Maryland School of Medicine, in Baltimore, Maryland. He has numerous publications in the areas of stroke risk factors and prevention, particularly novel risk factors and the epidemiology of stroke in young adults. His work established the post partum period as a time of increased stroke risk, rather than pregnancy per se. He has been Principal Investigator of grants from the NIH, CDC, AHA, and the VA related to the epidemiology and genetics of stroke, including the Stroke Prevention in Young Women Study. He served as a consultant to NIH on its Oral Contraceptive and Stroke Risk Program and to the FDA on Stroke Risk associated with Phenylpropanolamine. He was a member of the International Headache Society Task Force on Migraine, Oral Contraceptives, and Hormone Replacement Therapy. Currently, he is a member of the Stroke Statistics Subcommittee of the American Heart Association. He received the Golden Hammer Award for Dedication to Patient Care and Excellence in Neurologic Care from the residents at the University of Maryland and was elected as member of the American Neurological Association and the American Epidemiological Society.
Randolph S. Marshall, M.S., M.D.
Dr. Marshall is Professor of Neurology at Columbia University Medical Center and Director of the Stroke Division in the Department of Neurology. Dr. Marshall obtained his undergraduate degree from Harvard College in 1982 and his medical degree from the University of California in 1988, including an M.D. degree from UC San Francisco and a Master's degree in sociolinguistics from UC Berkeley. He completed his neurology residency in 1992 at Columbia and subsequently trained as a clinical and research fellow in cerebrovascular diseases at Columbia-Presbyterian Medical Center. His clinical work focuses on the treatment and prevention of stroke and related cerebrovascular disorders. He has been continuously funded from the NIH with a research program that investigates the hemodynamic and physiological mechanisms of acute stroke and stroke recovery, with emphasis on the functional neuroimaging correlates of brain plasticity and recovery after injury. He has also been involved in restorative treatment modalities after brain injury. Current NIH grants include a Program Project (SPOTRIAS) grant from NINDS to advance treatment and diagnosis of acute stroke. He is the Principal Investigator of one of the SPOTRIAS projects, a functional MRI study in acute stroke patients to identify patterns of brain activity that predict subsequent recovery of function, as well as the Principal Investigator of a multi-center clinical trial to assess the effects of extracranial-intracranial bypass surgery on cognition in patients with cerebral blood flow impairment from carotid artery occlusion. He sits on the New York City Stroke Directors Committee and is a member of the New York State Department of Health Stroke Advisory Council.
Lewis B. Morgenstern, M.D.
Dr. Morgenstern is Director of the Stroke Program at the University of Michigan Health System in Ann Arbor Michigan, USA. He is Professor of Neurology, Emergency Medicine and Neurosurgery at the University of Michigan Medical School and Professor of Epidemiology at the University of Michigan School of Public Health. Dr. Morgenstern is Medical Director of the Stroke Unit at University Hospital in Ann Arbor. He received his M.D. from the University of Michigan with Distinction in Research. He did his neurology residency at the Johns Hopkins Hospital, and then a stroke fellowship at the University of Texas at Houston. Dr. Morgenstern is an NIH funded Principal Investigator in studies that aim to reduce stroke health disparities with respect to race, ethnicity and gender. Dr. Morgenstern's research group has published studies identifying gender-specific disparities with respect to stroke symptoms, and differences in quality of stroke care. Dr. Morgenstern's other research focus is on the treatment of intracerebral hemorrhage, and mobilizing health care professionals and communities to treat acute ischemic stroke. He has an extensive publication record. Dr. Morgenstern is a fellow of the American Academy of Neurology and the American Heart Association and a member of the Editorial Board of the journal STROKE.
Ralph L. Sacco, M.D., M.S., F.A.H.A., F.A.A.N.
Ralph L. Sacco, MD, MS, is the Chairman of Neurology, Olemberg Family Chair in Neurological Disorders, Miller Professor of Neurology, Public Health & Epidemiology, Neurosurgery and Human Genetics and Executive Director of the Evelyn F. McKnight Brain Institute at the Miller School of Medicine, University of Miami and Chief of the Neurology Service at Jackson Memorial Hospital. A graduate of Cornell University, and a cum laude graduate of Boston University School of Medicine, he also holds a master’s in epidemiology from Columbia University, School of Public Health. Dr. Sacco completed his neurology residency training and postdoctoral training in stroke and epidemiology at Columbia Presbyterian in New York. He was previously Professor of Neurology, Chief of the Stroke and Critical Care Division, and Associate Chairman at Columbia University.
Principal Investigator of the Northern Manhattan Study (NOMAS), as well as co-investigator of multiple other NIH grants, Dr. Sacco has published extensively with over 300 peer-reviewed articles in the areas of stroke prevention, treatment, epidemiology, risk factors, human genetics, and stroke recurrence. He has been the recipient of numerous awards including, the Feinberg Award for Excellence in Clinical Stroke, the Chairman’s Award from the American Heart Association, and the NINDS Javits Award in Neuroscience.
Dr. Sacco is a fellow of both the Stroke and Epidemiology Councils of the American Heart Association and a former Board of Directors member of the American Academy of Neurology. He is a member of the American Association of Physicians and the American Neurological Association. He was the first neurologist to serve as President of the American Heart Association, 2010-11.
Jeffrey L. Saver, M.D.
Dr. Saver is Director of the UCLA Comprehensive Stroke Center and Professor of Neurology at the David Geffen School of Medicine, University of California, Los Angeles. Dr. Saver received his medical degree from Harvard Medical School in 1981, and is a graduate of the Harvard-Longwood Neurology Training Program, the University of Iowa Fellowship Program in Behavioral Neurology and Cognitive Neuroscience, and the Brown University Fellowship Program in Vascular Neurology. An author or co-author of over 430 research articles, 2 books, and 35 book chapters, Dr. Saver's research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke. Dr. Saver has held numerous leadership positions in neurovascular and translational science organizations, including having served as Chair of the Stroke Council, Chair of the Scientific Statements Oversight Committee, and Chair of the Performance Measures Oversight Committee of the American Heart Association/American Stroke Association and as Principal Investigator of the NIH-NINDS Field Administration of Stroke Magnesium (FAST-MAG) clinical trial. Having served on the Editorial Boards of numerous journals, he is currently Associate Editor at JAMA, the Journal of the American Medical Association, as well as Consulting Editor at the journal Stroke.
Sean I. Savitz, M.D.
Sean Savitz, MD is an Associate Professor of Neurology and director of the Stroke Program at the University of Texas Medical School in Houston. He graduated from Harvard College, received his MD from Albert Einstein College of Medicine, and completed neurology residency training and a cerebrovascular fellowship at the Harvard Medical School Neurology Training Program. He is a physician-scientist investigating novel treatment approaches including stem cell therapies for cerebrovascular disease and is the author of over 100 publications in the biomedical literature. Dr. Savitz oversees a bidirectional laboratory and clinical research program in stroke and is conducting some of the first clinical trials testing stem cell therapies in stroke. He is funded by grants from the National Institute of Health and the Howard Hughes Medical Institute.
Donald G. Stein, Ph.D.
Dr. Stein is a neuroscientist and Asa G. Candler Professor of Emergency Medicine at Emory University in Atlanta, Georgia. Dr. Stein served Emory for five years as Vice Provost for Graduate Studies, Dean of the Graduate School of Arts and Sciences, and acting Vice President for Research. He also served in a similar capacity at Rutgers University before joining the faculty at Emory. For more than 40 years, his research has focused on examining the processes underlying recovery of function after traumatic injury to the brain. Dr. Stein's lab was one of the first to demonstrate sex differences in the outcome of severe injuries to the frontal cortex, and how recovery was related to the hormonal state of females at the time of injury. Most recently this work culminated in the first successful clinical trial with progesterone in moderate to severe acquired brain injury. Patients given progesterone for 4 days post-injury had almost 60% less mortality and significantly better functional outcomes than patients given state-of-the-art treatment and placebo. His current research focuses on determining the physiological substrates responsible for progesterone's beneficial effects in the treatment of both permanent and transient ischemic stroke. He is past president of the International Brain Injury Association and serves currently on the National Advisory Council to the National Institute of Child Health and Human Development.